Search

Search Constraints

You searched for: Author/Creator Armstrong, Andrew J

Search Results

11. Nivolumab plus rucaparib for metastatic castration-resistant prostate cancer: results from the phase 2 CheckMate 9KD trial. Issue 8 (17th August 2022)